Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 7017-7024

  Magner, W J ^a   Kazim, A L ^a   Stewart, C ^a   Romano, M A ^a   Catalano, G ^a   Grande, C ^a   Keiser, N ^a   Santaniello, F ^a   Tomasi, T B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; ENZYME INHIBITOR; GAMMA INTERFERON; HISTONE; HISTONE DEACETYLASE INHIBITOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ACETYLATION; ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; TUMOR CELL CULTURE; TUMOR IMMUNITY;

EID: 0034671618     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.7017     Document Type: Article

References (50)

1. Regulation of transcription of MHC class II genes
2. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator
3. Regulation of MHC class II lessons from a disease
4. Site α is crucial for two routes of IFNγ-induced MHC class 1 transactivation the ISRE-mediated route and an novel pathway involving CIITA
5. Induction of MHC class I expression by the MHC class II transactivator CIITA
6. Regulation of MHC class I and II gene transcription differences and similarities
7. The IFNγ receptor a paradigm for cytokine receptor signaling
8. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA
9. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA acquisition of antigen processing and presentation capacity
10. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7 1 cell-based tumor vaccines
11. Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth
12. Immunologic nonresponsiveness to tumors
13. HLA class 1 antigen downregulation in human cancers T-cell immunotherapy revives an old story
14. Epigenetics regulation through repression
15. Nuclear histone acetylases and deactylases and transcriptional regulation HATs off to HDACs
16. Gene silencing Methylation meets acetylation
17. 2 phases by trichostatin A
18. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase) dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway
19. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation
20. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression
21. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression
22. Expression of the co-stimulatory molecule CD40 on melanoma cells
23. Thirteen genes (Cebpb E2fI, Tc4, Cyp24, Pck1, Acra4, Edn3, Kcnb1, Mc3r, Ntsr, Cd40, Plcg1 and Rcad) that probably lie in the distal imprinting region of mouse chromosome 2 are not monoallelically expressed
24. Real time quantitative PCR
25. Immunophenotyping
26. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)
27. Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes
28. Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2 2 5
29. Level of mIa expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle
30. Cell cycle and the differential expression of HLA-A, B and HLA-DR antigens on human B lymphoid cells
31. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
32. Mice lacking the transcription factor CIITA a second look
33. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator
34. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion
35. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo
36. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression
37. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes
38. CREB regulates MHC class II expression in a CIITA-dependent manner Immunity
39. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes
40. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression
41. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase
42. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
43. Methylation of class II trans-activator promoter IV a novel mechanism of MHC class II gene control
44. Synergy of demethylation and histone deacetylase inhibition in the reexpression of genes silenced in cancer
45. Active repression of major histocompatibility complex class I genes in a human neuroblastoma cell line
46. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis
47. CD40 and CD154 in cell-mediated immunity
48. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation
49. + T cells
50. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription